Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Resectable Pancreatic Cancer 1Pancreatic Neoplasms 1Adenocarcinoma 1

Interventions

pembrolizumab 70Cyclophosphamide 46Cisplatin 42Nivolumab 33Radiotherapy 30Paclitaxel 30Gemcitabine 30Carboplatin 28Docetaxel 26Dexamethasone 22atezolizumab 20Blood Specimen Collection 20Bevacizumab 19Rituximab 18Radiosurgery 18Fluorouracil 18fludarabine 17Magnetic Resonance Spectroscopy 17Leucovorin 17Lenalidomide 17Surveys and Questionnaires 16Oxaliplatin 16Doxorubicin 15Irinotecan 14Etoposide 14palbociclib 13Vincristine 13Radiotherapy, Intensity-Modulated 13Prednisone 13Letrozole 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × paricalcitol × 90 days × Clear all
NCT03415854 2026-05-12

NABPLAGEMD

HonorHealth Research Institute

Phase 2 Completed
34 enrolled 11 charts
Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

NCT03138720 2026-04-22

Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

HonorHealth Research Institute

Phase 2 Completed
40 enrolled 22 charts
Gastrointestinal

Resectable Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡